CYTOVAC A/S: Financial statements 2021
CVR: 31262666
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 960,000 and a net result of DKK -13,352,000 compared with DKK -15,696,000 the year before. That is a decrease of 4% compared with the year before. The profit margin was -1,390.8%. Equity in the 2021 report amounted to DKK -66,983,000.
- Revenue
- DKK 960,000
- Profit/Loss
- DKK -13,352,000
- Equity
- DKK -66,983,000
- Total Assets
- DKK 2,976,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 960K | - | -13.4M | -67M | - |
| 2020 | 1M | - | -15.7M | -53.6M | - |
| 2019 | - | - | -34.1M | -37.9M | - |
| 2018 | - | - | -30.4M | -3.8M | - |
| 2017 | - | -11.5M | -14.9M | 3.5M | 14 |
Official annual report
Find more companies like CYTOVAC A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
CYTOVAC A/S has published its annual report for 2020. Revenue came to DKK 1,000,000, and the net result was DKK -15,696,000.
As of June 2, 2021, Claus Toftkjær has joined the board of directors of CYTOVAC A/S.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.
